COPYRIGHT© 2018 吉林紫鑫药业股份有限公司
Announcement of Jilin Zixin Pharmaceutical Co., Ltd. on the return of raised funds
Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2013-021
Jilin Zixin Pharmaceutical Co., Ltd.
Announcement on the return of raised funds
Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as “the company”) reviewed and approved the “Thirty-eighth Meeting of the 4th Board of Directors” held on November 18, 2012, regarding the temporary replenishment of working capital by using part of the idle raised funds. The Bill agrees that the company will use the 50 million yuan idle raised funds to temporarily replenish the working capital, and the period of use will not exceed six months, from November 19, 2012 to May 18, 2013. For details of the use of some of the idle raised funds to temporarily supplement the working capital, please refer to the “Securities Times”, “China Securities Journal”, “Shanghai Securities News”, “Securities Daily” and www.cninfo.com.cn on November 20, 2012. .cninfo.com.cn) Announcement of Jilin Zixin Pharmaceutical Co., Ltd. on the temporary replenishment of working capital using some idle raised funds (2012-045).
On May 17, 2013, the company returned all of the above-mentioned funds raised from the temporary replenishment of working capital of 50 million yuan to the fundraising account, and the use period was less than 6 months. The company has notified the sponsor institution Northeast Securities Co., Ltd. and the sponsor representative of the return of the above raised funds.
Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors
May 18, 2013